Lung cancer screening: achieving a reduction in mortality

Semin Roentgenol. 2011 Jul;46(3):230-40. doi: 10.1053/j.ro.2011.02.007.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Incidence
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / mortality*
  • Lung Neoplasms / pathology
  • Mass Screening / methods*
  • National Cancer Institute (U.S.)
  • Neoplasm Staging
  • Prevalence
  • Radiation Dosage
  • Randomized Controlled Trials as Topic
  • Tomography, X-Ray Computed*
  • United States / epidemiology